{"name":"Apollo Therapeutics Ltd","slug":"apollo-therapeutics-ltd","ticker":"","exchange":"","domain":"apollo.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":5,"colorKey":"oncology","drugs":[{"name":"APL-9796","genericName":"APL-9796","slug":"apl-9796","indication":"Phase 2 for [insert indication here, if known]","status":"phase_2"},{"name":"Azacitidine and APL-4098","genericName":"Azacitidine and APL-4098","slug":"azacitidine-and-apl-4098","indication":"Other","status":"phase_1"},{"name":"APL-10456-Vaccine","genericName":"APL-10456-Vaccine","slug":"apl-10456-vaccine","indication":"Other","status":"phase_1"},{"name":"APL-4098","genericName":"APL-4098","slug":"apl-4098","indication":"Other","status":"phase_1"},{"name":"APL-5125","genericName":"APL-5125","slug":"apl-5125","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"APL-9796","genericName":"APL-9796","slug":"apl-9796","phase":"phase_2","mechanism":"APL-9796 is a small molecule that targets the [insert target here, if known].","indications":["Phase 2 for [insert indication here, if known]"],"catalyst":""},{"name":"Azacitidine and APL-4098","genericName":"Azacitidine and APL-4098","slug":"azacitidine-and-apl-4098","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"APL-10456-Vaccine","genericName":"APL-10456-Vaccine","slug":"apl-10456-vaccine","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"APL-4098","genericName":"APL-4098","slug":"apl-4098","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"APL-5125","genericName":"APL-5125","slug":"apl-5125","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxNMFNIeFdkcjQ2dzBmVlQ2LTQtbzhuaDlYRXNfTy1scHhBMEdGQ0NWYUJCalNZUzUycnVEZ3Bxc2ZpQnNqYlpOdkR3VE9jMzlrRXlKT0tGS3pxZ05CYUJuWS1lLVczM3RTZV9pRV96UjVrTF8wak5EWDU5MDBYZmpOdHZSNDBJR3BpdGE4QzdFLVp0b1VhRzlicm5aQTJoOXhiSEl6Ylkxalp5NndGRVRyZUtzS2JGOU8wUkR6LQ?oc=5","date":"2026-03-26","type":"pipeline","source":"Sahm","summary":"Geron Announces Appointment of New Members to its Board of Directors - Sahm","headline":"Geron Announces Appointment of New Members to its Board of Directors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE9UMG5mMUdWbk5Ma2VCMi1xWHdTcEp0ME4xZHR5WEdodFlyMGVXTS1xRDNHNEo1eUZVU2hOdWVpUV9OOUVyclFyd200b200THpOdVNYUjhqSmtWMUhCaVHSAWNBVV95cUxORWdJSGk0dXZRNlRGU3dpLXppR0hId1RoMFNGWmNLZ3M0Wk1lcGFlOFFJTUVUa2dFTnlhLXBIZ3pfdUV4SEpiYlFhY0RuWjU0TWlHM0Fsb25LR3lfT2d6ZUota1k?oc=5","date":"2026-03-25","type":"pipeline","source":"Bitget","summary":"Geron Announces Appointment of New Members to its Board of Directors - Bitget","headline":"Geron Announces Appointment of New Members to its Board of Directors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxNdEdOazNGb0ZEU2ZOUllGdGxLSmlWTUIzWWI4VjZZemd3RF9NYjF1YzlrYzliZjMxcFNJYnRzdVBKWkJUdFBMZGd5RDJsZXJZd1J3ZFdPbXNfbFJ5eVpSWHc4aUdHb3N0eVNiR05ybkNOSmxJRWplV1lQMkYtWGpUUWpJeE1SOHZmTllZZXFCNEs?oc=5","date":"2026-01-05","type":"pipeline","source":"Yahoo Finance","summary":"NRx Pharmaceuticals (Nasdaq:NRXP) and neurocare Group AG Announce Joint Offering of Neuroplastic Therapy Targeting Depression, PTSD, and other mental health afflictions - Yahoo Finance","headline":"NRx Pharmaceuticals (Nasdaq:NRXP) and neurocare Group AG Announce Joint Offering of Neuroplastic Therapy Targeting Depre","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxNWk5QY1A2c0Ryc0dobWlGYk1rdUZpQnVNeXQ4NWh2RENmMXh2UjNzcXJXU1piVEstcElUSk82Q2ZXUFhDaHo4SE1uamJBdDJ5LWFoTHZ2UUNTdFB0b3ZuNzUxaXlyMVU3SnFobTdlOFBwZzRrTVlJVHZVV2M1UTZSWThfMngtS1pFRVJr?oc=5","date":"2025-12-04","type":"trial","source":"Yahoo Finance","summary":"Acute Myeloid Leukemia Clinical Trial Pipeline Appears Robust With 100+ Key Pharma Companies Actively Working in the Domain | DelveInsight - Yahoo Finance","headline":"Acute Myeloid Leukemia Clinical Trial Pipeline Appears Robust With 100+ Key Pharma Companies Actively Working in the Dom","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-11-28","type":"pipeline","source":"The Economic Times","summary":"Apollo Pharmacy targets 10 crore customer base in 5 years, to open 2 new stores per day: CEO - The Economic Times","headline":"Apollo Pharmacy targets 10 crore customer base in 5 years, to open 2 new stores per day: CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxQemkyUWtFVmN1bDQ5YU1CbVlmTVdSVnhxUGlFaTlVMkNZVkFRTHo3OU5PNXBwWWJPMVRRSjh0dDFFd1FKMUpULXozN1IzMnBNRnlEY3dSalBCWlJIdWpidVVVMFVtb1BJc19OSFg2Z3M0RDVjVFhrM1M3eUdkZVNYVmFhR3ZKM2NjYnVFZTlVQ0dtZmZybmtNMkxmN0FzXzljZXBaWEFKUzktX1dhcEJQbHRsWHQ0a3hrY19ranBlZTNrZF9Z?oc=5","date":"2025-08-19","type":"deal","source":"Citeline News & Insights","summary":"China-Originated Assets Lead Global GLP-1 Deals - Citeline News & Insights","headline":"China-Originated Assets Lead Global GLP-1 Deals - Citeline News & Insights","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-06-13","type":"earnings","source":"NDTV Profit","summary":"Stocks To Buy: Apollo Hospitals, Max Healthcare, Tech Mahindra, Torrent Pharma, SRF - NDTV Profit","headline":"Stocks To Buy: Apollo Hospitals, Max Healthcare, Tech Mahindra, Torrent Pharma, SRF","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE5tbllFU1Vwd05FN0N0dEd6a21oNU9HbmdmbnhMbHBmQS1xWUsxa1RTbHpwZ19wUEhkeEg4a1lWYlI4dmVDTVpmUFllRnV5RHB1SE1lZzJ6Z2pSUEM4amFmYlNtck5LTEhYNkE?oc=5","date":"2025-02-09","type":"pipeline","source":"Business Weekly","summary":"Apollo Therapeutics - Business Weekly","headline":"Apollo Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxQbGl2VE0yR1dLRXdpTnJIcC12REhSbnhaRDBsc25uNFBnNkYteF82MXU4emdNLTFFVzlIQWExVG1ocXkzZlRsbFlibE81Y1JoejU5ei1EMFJDYjlLSEwydlEtRmFBTk1YRnhGdl9Wc2FzT3hkcHVNTFJTaWQ5ZU9zS0dhUFNJOU9hX0I1TVB5VEZib3ZhaDg3RS1EcnhjSXpnZmgyeA?oc=5","date":"2024-11-13","type":"deal","source":"BioWorld News","summary":"Apollo signs near-$1B deal for Sunshine’s FGF21/GLP-1 injection - BioWorld News","headline":"Apollo signs near-$1B deal for Sunshine’s FGF21/GLP-1 injection","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxNbXBrTGVpa3hJOEJCa0l1Z0hXMmVHSGhxbUFxcERmRVBPdUx3YmFmVHdRM1E1QWtyWlo5NG9uUFlERlZwX2tVc0pfd1I1a2ZZa1hsNGthZWh6WG9CaEhsVXY2OVNXOUU5bXVnODZ1Nzk3cDlJQ0lXVnZXY0oxTU1WUjFRdk42cHlYd0c4bFBaUnNkOV9nNE1OSkgwR2liWTVCVFZGVjFQVlpHTlJrNFNnaTNZWjZXQQ?oc=5","date":"2024-07-22","type":"deal","source":"University of Oxford","summary":"Apollo Therapeutics and Oxford University enter into drug discovery and development collaboration - University of Oxford","headline":"Apollo Therapeutics and Oxford University enter into drug discovery and development collaboration","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_wFBVV95cUxQUWthRjBUTk1McWJvY0dodUlsTnV2Q3FRcm9FY3hFSmk0LVRHX3JSRnJQRXNlZnFsczg5SWg2SFA0T21KTXBaRVNjd2pLcVZzMUpWcVVRMEs1LXRjZlkzMnJzbUp2YktadjEwd2FyTllBYmh4alQybXBvcFE4RzY0b19oWTdLVkpnMG5JU3BXa2x3UlhvYl9yTUIyY2x0cmtJUkRsaGlmaGwyeURiT2Vvb0dTMDRZRUdTRTlGQXA0Z1FoQlV2aDVBZThEdGctSkxkdHNieEpST2lLMGFaRnNPZlhPdzJvSjNDYlRPWHl2N19wOWtFWFdEYjc4VHNXU0k?oc=5","date":"2024-01-02","type":"pipeline","source":"Business Wire","summary":"Apollo Therapeutics Announces Second Close of Series C Financing Bringing Total Raised in Round to $260 Million - Business Wire","headline":"Apollo Therapeutics Announces Second Close of Series C Financing Bringing Total Raised in Round to $260 Million","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxQaGQ1a2h0XzBHWjlEZWhGMU1aV2h0N0VvNU9oOEUxR2ZNbldJQjJ4NUlIeDVQa1dnZ3FfUHJSN09UOFFKeU1tNEpKaUUtbzNtTVNwSlp1OHBpY0kyTkpaazN6WEY3Wk5pSy0zdGJwUVhidzlJa08yU1JfcFVQNG1mR0hJNlV5OUp5Ql9fVkFCSmNNd05xY2t5U2M1UlR4SUFLSjlr?oc=5","date":"2016-01-25","type":"pipeline","source":"University College London","summary":"UCL joins consortium to launch £40 million Apollo Therapeutics Fund | UCL News - UCL - University College London","headline":"UCL joins consortium to launch £40 million Apollo Therapeutics Fund | UCL News - UCL","sentiment":"neutral"}],"patents":[],"drugCount":5,"phaseCounts":{"phase_2":1,"phase_1":4},"enrichmentLevel":2,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}